The NRFC has tipped $150m into Brandon Capital’s sixth fund, taking it to $439m and pushing the government investor past its $550m FY25 target. The cash targets late and early-stage medtech, aiming to keep commercialisation onshore.
Australian VC firm, Brandon Capital Partners, has just raised another $210 million to invest in commercialising medical research, and is already on the hunt for another $250 million as it edges towards $1 billion in science investments. The 5th Medical Research Commercialisation Fund, MRCF5, raised AU$210 million from existing investors, taking the total in the… Read more »
Daily startup news and insights, delivered to your inbox.
